Microbiota‐Derived Butyrate Preserves Epithelial Integrity Through SIRT1 ‐Mediated Metabolic‐Epigenetic Crosstalk in Vulvar Lichen Sclerosus
The FASEB Journal · 31.03.2026 · 40 (6)
DOI: 10.1096/fj.202502946rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 17.03.2026. Verfasst von Yuanyuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Wenzhou People's Hospital, Wenzhou, China. Hauptthemen laut MEDLINE: Sirtuin 1, Vulvar Lichen Sclerosus, Microbiota, Epigenesis, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Wenzhou Science and Technology Bureau, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Vulvar lichen sclerosus (VLS) is increasingly understood as a disorder shaped by systemic immune–metabolic disturbances and microbiome dysregulation. This study investigated how temporal changes in the gut and reproductive tract microbiota influence gene expression, metabolic status, and therapeutic responses in VLS. Fecal and vaginal samples from 20 VLS patients and 20 healthy women were collected at baseline and four follow‐up time points and analyzed using multi‐omics profiling. VLS patients exhibited consistently reduced microbial diversity, with increased abundances of Prevotella and Gardnerella and decreased Bifidobacterium and Lactobacillus . These microbial shifts were accompanied by significant upregulation of inflammatory genes ( IL‐6 and TNF‐α ) and downregulation of metabolic regulators ( FOXO3 and SIRT1 ), with dynamic changes closely paralleling clinical progression. Metabolomic analysis further revealed marked disruptions in lipid and carbohydrate metabolism, particularly reduced levels of short‐chain fatty acids (SCFAs). Functional assays demonstrated that patient‐derived microbiota impaired cellular homeostasis by suppressing proliferation, enhancing apoptosis, and amplifying inflammatory signaling in vulvar epithelial and fibroblast models. In vivo, SCFA supplementation most effectively restored SIRT1 expression, reduced inflammatory cytokines, and improved metabolic balance in a DMBA‐induced VLS mouse model. Together, these findings highlight a mechanistic link between microbiome dysbiosis, inflammatory activation, and metabolic dysfunction in VLS. They also underscore the therapeutic potential of targeting microbial and metabolic pathways, providing a foundation for microbiome‐informed and personalized interventions for VLS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Wenzhou People's Hospital, Wenzhou, China.
ORCID-Profile: Haizhen He
Förderung
- Wenzhou Science and Technology Bureau
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Chen, Y., Pan, J., Li, R., Lin, W., Ye, Y., Chen, B., & He, H. (2026). Microbiota‐Derived Butyrate Preserves Epithelial Integrity Through SIRT1 ‐Mediated Metabolic‐Epigenetic Crosstalk in Vulvar Lichen Sclerosus. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202502946rr
Vancouver
Chen Y, Pan J, Li R, Lin W, Ye Y, Chen B, et al. Microbiota‐Derived Butyrate Preserves Epithelial Integrity Through SIRT1 ‐Mediated Metabolic‐Epigenetic Crosstalk in Vulvar Lichen Sclerosus. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202502946rr
BibTeX
@article{Chen2026,
author = {Chen, Yuanyuan and Pan, Jiajia and Li, Renliang and Lin, Wenjing and Ye, Yan and Chen, Bi and He, Haizhen},
title = {Microbiota‐Derived Butyrate Preserves Epithelial Integrity Through SIRT1 ‐Mediated Metabolic‐Epigenetic Crosstalk in Vulvar Lichen Sclerosus},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {6},
doi = {10.1096/fj.202502946rr}
}
EUVIMED